Isoniazid preventive therapy added to ART to prevent TB: an individual participant data meta-analysis
<p><strong>Background:</strong> Isoniazid preventive therapy prevents active tuberculosis in people with HIV, but previous studies have found no evidence of benefit in people with HIV who had a negative tuberculin skin test, and a non-significant effect on mortality. We aimed to es...
Main Authors: | Ross, J, Badje, A, Rangaka, M, Walker, AS, Shapiro, A, Thomas, K, Anglaret, X, Eholie, S, Gabillard, D, Boulle, A, Maartens, G, Wilkinson, RJ, Ford, N, Golub, J, Williams, B, Barnabas, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2021
|
Similar Items
-
Children and providers’ perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
by: A.J. Marthinus, et al.
Published: (2025-01-01) -
Underutilization of isoniazid drug therapy to prevent TB disease progression in Swaziland
by: B. Cronin, et al.
Published: (2015-03-01) -
Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis
by: Emily A. Kendall, et al.
Published: (2021-12-01) -
Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
by: R. Borse, et al.
Published: (2024-09-01) -
Delivery of isoniazid preventive therapy to reduce occupational TB among healthcare workers in Swaziland
by: Marianne Calnan, et al.
Published: (2017-03-01)